{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:38:52Z","timestamp":1794281932275,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s10067-015-3023-x","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T19:03:34Z","timestamp":1438110214000},"page":"1563-1569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)"],"prefix":"10.1007","volume":"34","author":[{"given":"Jorge","family":"Rojas-Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Herrera-Bringas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermes","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidegger","family":"Mateos-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"issue":"6","key":"3023_CR1","first-page":"360","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Med Chem Commun 70(6):360\u2013374","journal-title":"Med Chem Commun"},{"issue":"4-5","key":"3023_CR2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13(4-5):367\u2013371","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3023_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","volume":"14","author":"I Marie","year":"2012","unstructured":"Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Reports 14(3):275\u2013285","journal-title":"Curr Rheumatol Reports"},{"issue":"5","key":"3023_CR4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.21895","volume":"65","author":"I Marie","year":"2013","unstructured":"Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A, Cherin P, Mouthon L, Vittecoq O, Menard JF et al (2013) Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res (Hoboken) 65(5):800\u2013808","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"3023_CR5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Marie","year":"2012","unstructured":"Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP et al (2012) Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11(10):739\u2013745","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3023_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, Oddis CV (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73(1):227\u2013232","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3023_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","volume":"12","author":"B Hervier","year":"2012","unstructured":"Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B et al (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNAsynthetase antibody specificity. Autoimmun Rev 12(2):210\u2013217","journal-title":"Autoimmun Rev"},{"issue":"7","key":"3023_CR8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"8","key":"3023_CR9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"9842","key":"3023_CR10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","volume":"380","author":"A Fischer","year":"2012","unstructured":"Fischer A, Du BR (2012) Interstitial lung disease in connective tissue disorders. Lancet 380(9842):689\u2013698","journal-title":"Lancet"},{"issue":"12","key":"3023_CR11","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","volume":"49","author":"A Ghirardello","year":"2010","unstructured":"Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S, Zen M, Vattemi GA, Lundberg IE, Doria A (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49(12):2370\u20132374","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3023_CR12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2214\/ajr.169.4.9308447","volume":"169","author":"EA Kazerooni","year":"1997","unstructured":"Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL, Cascade PN, Whyte RI, Lynch JP III, Toews G (1997) Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR AmJRoentgenol 169(4):977\u2013983","journal-title":"AJR AmJRoentgenol"},{"issue":"11","key":"3023_CR13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Critical Xare Med 177(11):1248\u20131254","journal-title":"Am J Respir Critical Xare Med"},{"issue":"7","key":"3023_CR14","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-203605","volume":"72","author":"B Hervier","year":"2013","unstructured":"Hervier B, Devilliers H, Benveniste O (2013) Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 72(7), e18","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3023_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC (1996) Interstitial lung disease with autoantibodies against aminoacyl-tRNAsynthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26(1):459\u2013467","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"3023_CR16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M et al (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNAsynthetase antibodies: heterogeneity within the syndrome. PLoS One 8(4), e60442","journal-title":"PLoS One"},{"issue":"8","key":"3023_CR17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-013-0349-8","volume":"15","author":"B Hervier","year":"2013","unstructured":"Hervier B, Benveniste O (2013) Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr Rheumatol Rep 15(8):349","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"3023_CR18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/rheumatology\/ker132","volume":"50","author":"B Hervier","year":"2011","unstructured":"Hervier B, Lambert M, Hachulla E, Musset L, Benveniste O, Piette JC, Amoura Z, Costedoat-Chalumeau N (2011) Anti-synthetase syndrome positive for anti-isoleucyl-tRNAsynthetase antibodies: an unusual case overlapping with systemic sclerosis and Sjogren's syndrome. Rheumatology (Oxford) 50(6):1175\u20131176","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3023_CR19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1183\/09031936.00104310","volume":"37","author":"B Hervier","year":"2011","unstructured":"Hervier B, Uzunhan Y, Hachulla E, Benveniste O, Nunes H, Delaval P, Musset L, Dubucquoi S, Wallaert B, Hamidou M (2011) Antisynthetase syndrome positive for anti-threonyl-tRNAsynthetase (anti-PL7) antibodies. EurRespir J 37(3):714\u2013717","journal-title":"EurRespir J"},{"issue":"11","key":"3023_CR20","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63(11):3439\u20133447","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3023_CR21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","volume":"41","author":"I Marie","year":"2012","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41(6):890\u2013899","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"3023_CR22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","volume":"107","author":"K Tanizawa","year":"2013","unstructured":"Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Aihara K, Ikezoe K, Watanabe K, Taguchi Y, Hatta K et al (2013) The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 107(5):745\u2013752","journal-title":"Respir Med"},{"issue":"9","key":"3023_CR23","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G et al (2014) Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. Rheumatology 53(9):1676\u20131682","journal-title":"Rheumatology"},{"key":"3023_CR24","doi-asserted-by":"crossref","unstructured":"Perez-Dorame R, Mejia M, Mateos-Toledo H, Rojas-Serrano J (2014) Rheumatoid arthritis-associated interstitial lung disease: Lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity. Reumatologiaclinica","DOI":"10.1016\/j.reumae.2014.02.015"},{"issue":"2","key":"3023_CR25","first-page":"68","volume":"8","author":"J Rojas-Serrano","year":"2012","unstructured":"Rojas-Serrano J, Gonzalez-Velasquez E, Mejia M, Sanchez-Rodriguez A, Carrillo G (2012) Interstitial lung disease related to rheumatoid arthritis: evolution after treatment. ReumatolClin 8(2):68\u201371","journal-title":"ReumatolClin"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3023-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-3023-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-3023-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:48:24Z","timestamp":1567010904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-3023-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["3023"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-3023-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}